Study of DE-089 Ophthalmic Solution in Patients With Dry Eye
NCT01101984
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
400
Enrollment
INDUSTRY
Sponsor class
Conditions
Dry Eye
Interventions
DRUG:
diquafosol ophthalmic solution
DRUG:
0.1% sodium hyaluronate ophthalmic solution.
Sponsor
Santen Pharmaceutical Co., Ltd.